A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil

Phase 1 Completed 60 enrolled Astellas Pharma Inc

RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is intended to determine the safety and tolerability of ASP0777 in subjects with Alzheimer's Disease (AD) taking a stable dose of donepezil.

Timeline

Start: 2011-06-16
Primary completion: 2011-11-04
Completion: 2011-11-04

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	ASP0777	Unknown	—	Oral

A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil

Summary

Timeline

Drugs

Indications